SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SPALLUTO, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.903
AS - Asia 1.543
EU - Europa 828
SA - Sud America 211
AF - Africa 17
OC - Oceania 1
Totale 5.503
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.844
CN - Cina 548
SG - Singapore 546
DE - Germania 182
UA - Ucraina 182
BR - Brasile 178
TR - Turchia 151
HK - Hong Kong 150
GB - Regno Unito 121
SE - Svezia 75
FI - Finlandia 68
VN - Vietnam 54
IT - Italia 49
RU - Federazione Russa 36
FR - Francia 30
CA - Canada 28
MX - Messico 28
IN - India 25
JP - Giappone 22
PL - Polonia 21
ES - Italia 15
AR - Argentina 14
AT - Austria 14
ZA - Sudafrica 14
BD - Bangladesh 10
NL - Olanda 9
LT - Lituania 8
BE - Belgio 6
EC - Ecuador 6
ID - Indonesia 5
JO - Giordania 5
CZ - Repubblica Ceca 4
PY - Paraguay 4
TW - Taiwan 4
IR - Iran 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CO - Colombia 2
IQ - Iraq 2
KZ - Kazakistan 2
MA - Marocco 2
PE - Perù 2
RS - Serbia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DM - Dominica 1
EG - Egitto 1
GY - Guiana 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
VE - Venezuela 1
Totale 5.503
Salva come PNG Salva come JPEG
Città #
Singapore 320
Woodbridge 272
Chandler 251
Ashburn 240
Houston 226
Fairfield 204
Jacksonville 198
Beijing 184
Ann Arbor 164
Hong Kong 150
Santa Clara 133
Nanjing 87
Wilmington 85
Izmir 75
Dallas 72
Seattle 65
Cambridge 53
Munich 49
Princeton 46
Los Angeles 44
Boardman 35
Dearborn 35
New York 33
Shanghai 25
Shenyang 22
São Paulo 21
Turku 21
Nanchang 19
Hefei 17
Ho Chi Minh City 17
San Diego 17
London 16
Milan 16
Brooklyn 15
Mexico City 15
Tianjin 15
Tokyo 15
Addison 14
Falkenstein 14
Frankfurt am Main 14
San Mateo 14
Vienna 14
Changsha 13
Warsaw 13
Buffalo 11
Jiaxing 11
San Francisco 11
Hanoi 10
Hebei 10
Atlanta 9
Chennai 9
Helsinki 9
Jinan 9
Moscow 9
Toronto 9
Bremen 8
Falls Church 8
Johannesburg 8
Kunming 8
Norwalk 8
Poplar 8
Zhengzhou 8
Boston 7
Chicago 7
Ningbo 7
Ottawa 7
Phoenix 7
Taizhou 7
Brussels 6
Orem 6
Philadelphia 6
Rio de Janeiro 6
Amman 5
Denver 5
Ferrara 5
Manchester 5
Montreal 5
Verona 5
Ankara 4
Mumbai 4
Olomouc 4
Queens 4
Tampa 4
The Dalles 4
Belo Horizonte 3
Bexley 3
Biên Hòa 3
Charlotte 3
Council Bluffs 3
Des Moines 3
Düsseldorf 3
Guangzhou 3
Haikou 3
Itanhaém 3
Itaquaquecetuba 3
Lanzhou 3
Maringá 3
Orange 3
Porto Alegre 3
Pune 3
Totale 3.699
Salva come PNG Salva come JPEG
Nome #
4-Isopropyl-2-oxazolin-5-one anion as a new convenient formyl anion equivalent for conjugate addition and aldol reactions 283
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 229
4-Isopropyl-2-oxazolin-5-one anion as masked umpoled synthon for both formyl and hydroxycarbonyl anions: generation, reactivity and synthetic applications 209
Enantioselective synthesis of (-)-meroquinene through tandem Michael reaction methodology 206
Changes in cortical ACh and GABA outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors 205
5‐Hydroxytryptamine‐mediated effects of nicotine on endogenous GABA efflux from guinea‐pig cortical slices 197
Mastering β-Keto Esters 189
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 186
A new synthetic approach to indazole synthesis 181
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 176
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 172
Effect of acute and subchronic nicotine treatment on cortical efflux of [3H]‐d‐aspartate and endogenous GABA in freely moving guinea‐pigs 171
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance 169
Alpha-1 adrenoreceptor-mediated increase in ACh release in brain slices during morphine tolerance 165
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity 161
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 153
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 151
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 150
7-sobstituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonist: importance of modifications at the side chain on the activity and solubility. 149
New potent and selective human adenosine A3 receptor antagonists 149
Generation and cycloaddition reactions of 3-substituted-2-nitro-1,3- dienes 148
Pyrazolo [4,3-E]1,2,4-triazolo[1,5-c]pyrimidine derivates a new class of potent and selective human A3 adenosine receptor antagonists. 115
Substituted 6-amino-thiouracils as new P2Y(12) receptor antagonists 114
Pharmacological and biochemical characterization of A3 adenosine receptor in Jurkat T cells. 112
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists 106
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 105
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies 105
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4,-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 104
Synthesis, binding and thermodynamic studies of new highly selective A2A adenosine receptor antagonists 101
Synthesis and pharmacological characterization of [3H]-MRE3008F20: the first radioligand antagonist for the human A3 adenosine receptors. 95
Synthesis and preliminary biological evaluation of [3H]-MRE 3008F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors 95
Synthesis, biological properties and molecular modelling investigation of the first potent, selective and water soluble human A3 adenosine receptor antagonist. 94
Pyrazolo-triazolo-pyrimidine as human A3 adenosine receptor antagonists: influence of the substitutent at N8 pyrazole nucleus. 91
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new pharmacological tool for the characterization of the human A(3) adenosine receptor 88
Pyrazolo [4,3-E]1,2,4-trazolo[1,5-c]pyrimidine derivatives a new class of potent and selective human A3 adenosine receptor antagonists 87
Pyrazolo-triazolo-pyrimidine derivates as adenosine receptor ligands: a search for A2B adenosine receptor antagonists. 86
Second generation of A2A adenosine receptor antagonist: synthesis and biological evaluation 84
Pyrazolo[4,3-e]1,2,4-triazolo[1,5]pyrimidine derivates as irreversible antagonists at the human A3 adenosine receptor 76
An efficient synthesis of 4-oxo-2,5-hexadienoates via Δ2-isoxazoline intermediates 63
Totale 5.520
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.558
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021234 0 0 0 0 0 38 10 42 13 40 69 22
2021/2022395 9 42 19 27 20 11 11 22 17 33 46 138
2022/2023488 41 44 6 78 82 74 16 50 63 2 18 14
2023/2024198 22 26 10 5 27 26 8 12 5 3 1 53
2024/2025902 15 24 66 54 98 74 28 49 115 116 129 134
2025/20261.421 288 91 220 380 397 45 0 0 0 0 0 0
Totale 5.520